Pretreatment of cancer cells with 5-aza-2’-deoxycytidine (DNA methylation inhibitor) before inoculation in mice led to increased TGF-β1 expression, tumor size reduction, and an extended survival time of animals [138]. This evidence concerns the gene TGFB1 and cancer.